Eplerenone

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Eplerenone and local guidelines before prescribing.

Aldosterone antagonist

Mechanism

Selective mineralocorticoid receptor antagonist.

Uses

Heart failure after MI, heart failure with reduced EF.

Dosing

Side effects

Hyperkalaemia, renal impairment, dizziness; fewer endocrine effects than spironolactone.

Interactions

CYP3A4 inhibitors (clarithromycin, ketoconazole) contraindicated; ACE inhibitors, ARBs, potassium raise potassium.

Contraindications and cautions

Potassium above 5.0 mmol/L, eGFR below 30, strong CYP3A4 inhibitors

Monitoring

Potassium, creatinine

Pregnancy and breastfeeding

Avoid unless essential

Renal and hepatic impairment

Avoid in severe renal impairment

Overdose and reversal

Supportive; treat hyperkalaemia

Special advice

Monitor potassium and creatinine early and regularly.

More from the textbook: uses, cautions and other points
Where it is discussed in the book